ChemicalBook >> CAS DataBase List >>Eliglustat (Tartrate)

Eliglustat (Tartrate)

CAS No.
928659-70-5
Chemical Name:
Eliglustat (Tartrate)
Synonyms
GENZ112638;Eligluhemitartrate;Eliglustat (Tartrate);Eliglustat (hemitartrate);Eliglustat tartrate (Genz-112638);GENZ-112638;GENZ 112638;GENZ112638;Eliglustat hemitartrate(Genz-99067);Eliglustat hemitartrate (Genz-112638);Eliglustat (Tartrate),Eliglustat tartrate;Genz112638,Inhibitor,Eliglustat,Genz 112638,inhibit,Eliglustat hemitartrate
CBNumber:
CB22667944
Molecular Formula:
C50H78N4O14
Molecular Weight:
959.17272
MDL Number:
MFCD22665712
MOL File:
928659-70-5.mol
Last updated:2023-05-18 11:31:07

Eliglustat (Tartrate) Properties

Melting point >133°C (dec.)
storage temp. -20°C Freezer, Under inert atmosphere
solubility DMSO (Slightly), Methanol (Slightly)
form Solid
color White
FDA UNII N0493335P3

Eliglustat (Tartrate) price More Price(11)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 21487 Eliglustat (hemitartrate) ≥98% 928659-70-5 1mg $32 2024-03-01 Buy
Cayman Chemical 21487 Eliglustat (hemitartrate) ≥98% 928659-70-5 5mg $139 2024-03-01 Buy
Cayman Chemical 21487 Eliglustat (hemitartrate) ≥98% 928659-70-5 10mg $243 2024-03-01 Buy
Cayman Chemical 21487 Eliglustat (hemitartrate) ≥98% 928659-70-5 25mg $533 2024-03-01 Buy
Usbiological 448126 Eliglustat Tartrate 928659-70-5 1mg $305 2021-12-16 Buy
Product number Packaging Price Buy
21487 1mg $32 Buy
21487 5mg $139 Buy
21487 10mg $243 Buy
21487 25mg $533 Buy
448126 1mg $305 Buy

Eliglustat (Tartrate) Chemical Properties,Uses,Production

Description

Eliglustat tartrate, developed and marketed by Genzyme Corporation (a subsidiary of Sanofi), was approved by the US FDA in August 2014 for the treatment of nonneuropathic (type 1) Gaucher disease (GD1) in both treatment-naive and treatment-experienced adult patients. It is the first oral treatment to be approved for first-line use in patients with Gaucher disease type 1, which is a rare lysosomal storage disease characterized by accumulation of lipid glucosylceramide (GL-1) due to insufficient production of the enzyme glucosylceramidase. Clinical complications include hepatosplenomegaly, anemia, thrombocytopenia, and bone involvement. Eliglustat is a specific inhibitor of glucosylceramide synthase with an IC50 of 10 ng/mL and acts as substrate reduction therapy for GD1; it has demonstrated non-inferiority to enzyme replacement therapy, which is the current standard of care, in Phase III trials.

Uses

Eliglustat Tartrate functions as an oral agent for treatment of Gaucher disease type 1, and lysosomal storage disorders in human. It also inhibits UDP-glucosylceramide synthase in mice thereby preventing Gaucher disease-associated with B-cell malignancy.

Definition

ChEBI: A tartrate that is the hemitartrate salt of eliglustat. A ceramide glucosyltransferase inhibitor used (as its tartrate salt) for treatment of Gaucher's disease.

Synthesis

Condensation of commercially available S-(+)-2-phenyl glycinol (87) with phenyl bromoacetate (88) in acetonitrile in the presence of N,N-diisopropylethylamine (DIPEA) provided morpholin-2-one 89 upon treatment with HCl. Neutralization with NaHCO3 followed by coupling with aldehyde 90 in refluxing EtOAc/toluene yielded oxazine adduct 91, which was isolated as a precipitate from methyl-tert-butyl ether (MTBE). The stereochemistry of the three new stereocenters in 91 can be rationalized through the cycloaddition of an ylide intermediate in the sterically-preferred S-configuration (generated by the reaction of the morpholinone 89 with aldehyde 90) with a second equivalent of the aldehyde. With the morpholinone in a chair conformation in which the phenyl group is equatorial, endo axial approach of the dipolarophile to the less-hindered face of the ylide and subsequent ring flip of the morpholinone ring to a boat conformation positions all exocyclic aryl substituents in a pseudoequatorial configuration. Opening of oxazine 91 with pyrrolidine in refluxing THF followed by addition of HCl in refluxing MeOH gave amide 92, which was reduced to amine 93 using LiAlH4 in refluxing THF. Subsequent hydrogenation with Pd(OH)2 in EtOH cleaved the phenylethanol group to give the free amine, which was converted to dioxalate salt 94 by treatment with oxalic acid in methyl isobutylketone (MIBK). Subjection of aminoethanol 94 to aqueous sodium hydroxide followed by coupling with palmitic acid Nhydroxysuccinimide (NHS)-ester (95) gave eliglustat as the corresponding freebase (96) in 9.5% overall yield from 87. Salt formation with L-tartaric acid (0.5 equiv) then provided eliglustat tartrate (XII).

Synthesis_928659-70-5

Eliglustat (Tartrate) Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 94)Suppliers
Supplier Tel Email Country ProdList Advantage
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32686 60
BOC Sciences
+1-631-485-4226 inquiry@bocsci.com United States 19553 58
career henan chemical co
+86-0371-86658258 15093356674; factory@coreychem.com China 29826 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 19892 58
Shanxi Xuanran Import and Export Trade Co., Ltd.
+8617735180244 mike_yan@xuanranglobal.com CHINA 4022 58
sgtlifesciences pvt ltd
+8617013299288 dj@sgtlifesciences.com China 12382 58
InvivoChem
+1-708-310-1919 +1-13798911105 sales@invivochem.cn United States 6393 58
Nantong HI-FUTURE Biology Co., Ltd.
+undefined18051384581 sales@chemhifuture.com China 3136 58
ShenZhen Trendseen Biological Technology Co.,Ltd.
13417589054 trendseenbio@gmail.com China 11681 58
Wuhan Topule Biopharmaceutical Co., Ltd
+8618327326525 masar@topule.com China 8474 58

View Lastest Price from Eliglustat (Tartrate) manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Eliglustat hemitartrate pictures 2019-12-29 Eliglustat hemitartrate
928659-70-5
US $2.00 / KG 1KG ≥98% 20 tons Career Henan Chemical Co

928659-70-5(Eliglustat (Tartrate))Related Search:

Eliglustat (Tartrate) Eliglustat (hemitartrate) Eliglustat hemitartrate(Genz-99067) GENZ112638 (2R,3R)-2,3-Dihydroxysuccinic acid - N-[(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-(1-pyrrolidinyl)-2-propanyl]octanamide (1:2) N-[(1R,2R)-1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]octanamide,(2R,3R)-2,3-dihydroxybutanedioic Acid Eliglustat hemitartrate (Genz-112638) GENZ-99067;GENZ99067;GENZ 99067;GENZ-112638;GENZ112638;GENZ 112638;ELIGLUSTAT TARTRATE Eliglustat tartrate (Genz-112638) GENZ-112638;GENZ 112638;GENZ112638 Eliglustat (Tartrate),Eliglustat tartrate Genz112638,Inhibitor,Eliglustat,Genz 112638,inhibit,Eliglustat hemitartrate N-((1R,2R)-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)octanamide ((2R,3R)-2,3-dihydroxysuccinate)(2:1) Eligluhemitartrate 928659-70-5 C50H78N4O14 1